Growth Metrics

SOPHiA GENETICS (SOPH) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$20.0 million.

  • SOPHiA GENETICS's Net Income towards Common Stockholders fell 858.55% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.2 million, marking a year-over-year increase of 2647.96%. This contributed to the annual value of -$62.5 million for FY2024, which is 2087.59% up from last year.
  • Per SOPHiA GENETICS's latest filing, its Net Income towards Common Stockholders stood at -$20.0 million for Q3 2025, which was down 858.55% from $22.4 million recorded in Q2 2025.
  • SOPHiA GENETICS's Net Income towards Common Stockholders' 5-year high stood at $24.7 million during Q2 2022, with a 5-year trough of -$25.5 million in Q1 2022.
  • Over the past 5 years, SOPHiA GENETICS's median Net Income towards Common Stockholders value was -$17.4 million (recorded in 2025), while the average stood at -$10.3 million.
  • Per our database at Business Quant, SOPHiA GENETICS's Net Income towards Common Stockholders tumbled by 30393.09% in 2021 and then soared by 23420.88% in 2022.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Net Income towards Common Stockholders stood at -$21.4 million in 2021, then surged by 34.64% to -$14.0 million in 2022, then tumbled by 72.21% to -$24.1 million in 2023, then surged by 37.0% to -$15.2 million in 2024, then plummeted by 32.08% to -$20.0 million in 2025.
  • Its last three reported values are -$20.0 million in Q3 2025, $22.4 million for Q2 2025, and -$17.4 million during Q1 2025.